Indoco Remedies Limited Market Cap ($207.64 Million)
Market Cap & Net Worth: Indoco Remedies Limited (INDOCO)
Indoco Remedies Limited market cap. Indoco Remedies Limited (NSE:INDOCO) has a market capitalization of $207.64 Million (Rs19.20 Billion) as of November 1, 2026. Listed on the NSE stock exchange, this India-based company holds position #16205 globally and #823 in its home market, demonstrating a -7.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Indoco Remedies Limited's stock price Rs208.30 by its total outstanding shares 92173705 (92.17 Million). Also see cash efficiency ratio of Indoco Remedies Limited for how efficiently the company converts equity into cash flow.
Indoco Remedies Limited Market Cap History (2015–2026)
Indoco Remedies Limited market cap history from 2015 to 2026. Data shows change from $314.27 Million to $207.64 Million (-3.61% CAGR). Check current stock price of Indoco Remedies Limited for real-time trading data and today's change.
Index Memberships
Indoco Remedies Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$139.63 Billion | 0.15% | #167 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.02 Trillion | 0.01% | #553 of 750 |
Weight: Indoco Remedies Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Indoco Remedies Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Indoco Remedies Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Indoco Remedies Limited equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.01x
Indoco Remedies Limited's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $273.12 Million | $10.97 Billion | $770.61 Million | 0.02x | 0.35x |
| 2018 | $211.87 Million | $10.18 Billion | $411.61 Million | 0.02x | 0.51x |
| 2019 | $187.80 Million | $9.42 Billion | -$29.04 Million | 0.02x | N/A |
| 2020 | $298.42 Million | $10.80 Billion | $241.17 Million | 0.03x | 1.24x |
| 2021 | $447.30 Million | $12.19 Billion | $930.46 Million | 0.04x | 0.48x |
| 2022 | $401.21 Million | $15.04 Billion | $1.55 Billion | 0.03x | 0.26x |
| 2023 | $392.35 Million | $16.40 Billion | $1.42 Billion | 0.02x | 0.28x |
| 2024 | $331.14 Million | $17.88 Billion | $984.60 Million | 0.02x | 0.34x |
| 2025 | $233.85 Million | $16.65 Billion | -$737.40 Million | 0.01x | N/A |
| 2026 | $207.64 Million | $18.45 Billion | -$987.00 Million | 0.01x | N/A |
Competitor Companies of INDOCO by Market Capitalization
Companies near Indoco Remedies Limited in the global market cap rankings as of November 1, 2026. Also see balance sheet size of Indoco Remedies Limited for a full breakdown of the balance sheet.
Key companies related to Indoco Remedies Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Indoco Remedies Limited (2015–2026)
Market capitalization of Indoco Remedies Limited from 2015 to today. Between 2015 and today, Indoco Remedies Limited's market cap moved from $314.27 Million to $ 207.64 Million, with a yearly change of -3.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs207.64 Million | -11.21% |
| 2025 | Rs233.85 Million | -29.38% |
| 2024 | Rs331.14 Million | -15.60% |
| 2023 | Rs392.35 Million | -2.21% |
| 2022 | Rs401.21 Million | -10.30% |
| 2021 | Rs447.30 Million | +49.89% |
| 2020 | Rs298.42 Million | +58.90% |
| 2019 | Rs187.80 Million | -11.36% |
| 2018 | Rs211.87 Million | -22.42% |
| 2017 | Rs273.12 Million | +8.48% |
| 2016 | Rs251.76 Million | -19.89% |
| 2015 | Rs314.27 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Indoco Remedies Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $207.64 Million USD |
| MoneyControl | $207.64 Million USD |
| MarketWatch | $207.64 Million USD |
| marketcap.company | $207.64 Million USD |
| Reuters | $207.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Indoco Remedies Limited
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides bra… Read more